SCHEMBL5585665

SCHEMBL5585665

CC(C)N(Cc1ccc(C(=O)O)cc1)c1nc(-c2ccc(NC(=O)c3ccc(C4CCCCC4)cc3)cc2)cs1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.46
HDAC11 Q96DB2 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
DEGS1 O15121 1/20 0.44
MCHR1 Q99705 1/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRK1 P41145 1/20 0.41
MRE11 P49959 1/20 0.41
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5585645 0.91 GCGR (0.43) HDAC3HDAC11HDAC8HDAC6MCHR1
SCHEMBL5999050 0.89 HDAC3 (0.48) HDAC3HDAC11HDAC8HDAC6DEGS1
SCHEMBL5585557 0.88 LIMK2 (0.46) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL5585850 0.86 MEN1 (0.54) MCHR1NPC1RAB9AMEN1KMT2A
SCHEMBL5585459 0.86 HDAC3 (0.48) HDAC3HDAC11HDAC8HDAC6DEGS1
SCHEMBL5585795 0.85 MAPT (0.46) MCHR1NPC1RAB9AMEN1KMT2A
SCHEMBL5585916 0.85 TRPM8 (0.41) MEN1KMT2AOPRM1OPRK1MRE11
SCHEMBL5585890 0.85 MRE11 (0.38) RAB9AMEN1KMT2AKDM4EALDH1A1
SCHEMBL5585411 0.85 FFAR1 (0.44) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL5585930 0.84 HDAC3 (0.46) HDAC3HDAC11HDAC8HDAC6DEGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7163952-B2 Azole compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2007-01-16 US disclosed
US-7163952-B2 Azole compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2007-01-16 US disclosed
US-20050065196-A1 Azole compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-24 US disclosed
EP-1452530-A1 AZOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065196-A1 Azole compound and medicinal use thereof PTPN7, PTPN1, PTPN5 HDAC3 1288/4885HDAC11 500/4885HDAC8 1266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.